Increasing participation in cervical cancer screening: Offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial

International Journal of Cancer

Volumn 134, Issue 9, 2014, Pages 2223-2230

  Broberg, Gudrun ^a,b   Gyrd Hansen, Dorte ^c   Miao Jonasson, Junmei ^d   Ryd, Mare Liis ^a   Holtenman, Mikael ^a   Milsom, Ian ^b   Strander, Björn ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

cervical intraepithelial neoplasia; HPV; mass screening; non attendance; papanicolaou smear

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLPOSCOPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HIGH RISK PATIENT; HPV SELF TEST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MIDDLE AGED; PAPANICOLAOU TEST; PATIENT PARTICIPATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SWEDEN; TELEPHONE INTERVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; HPV; MASS SCREENING; NON-ATTENDANCE; PAPANICOLAOU SMEAR;

ADULT; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; SELF CARE; SWEDEN; TELEPHONE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84896724250     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28545     Document Type: Article

References (29)

1. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005; 14: 677-86.
2. Gustafsson L, Ponten J, Zack M, et al. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997; 8: 755-63.
3. Mahlck CG, Jonsson H, Lenner P,. Pap smear screening and changes in cervical cancer mortality in Sweden. Int J Gynaecol Obstet 1994; 44: 267-72.
4. Andrae B, Kemetli L, Sparen P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008; 100: 622-9.
5. Lindqvist PG, Hellsten C, Rippe A,. Screening history of women in Malmo with invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 2008; 137: 77-83.
6. Broberg G, Jonasson JM, Ellis J, et al. Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial. Int J Cancer 2013; 133: 164-71.
7. Waller J, Bartoszek M, Marlow L, et al. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen 2009; 16: 199-204.
8. Oscarsson MG, Benzein EG, Wijma BE,. Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. J Psychosom Obstet Gynaecol 2008; 29: 23-31.
9. Eaker S, Adami HO, Sparen P,. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med 2001; 32: 482-91.
10. Segnan N, Senore C, Giordano L, et al. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Tumori 1998; 84: 348-53.
11. Morrell S, Taylor R, Zeckendorf S, et al. How much does a reminder letter increase cervical screening among under-screened women in NSW? Aust N Z J Public Health 2005; 29: 78-84.
12. Eaker S, Adami HO, Granath F, et al. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 346-54.
13. Gok M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010; 340: c1040.
14. Virtanen A, Anttila A, Luostarinen T, et al. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 2010; 128: 2681-7.
15. Virtanen A, Nieminen P, Luostarinen T, et al. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev 2011; 20: 1960-9.
16. Szarewski A, Cadman L, Mesher D, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening-a randomised controlled trial. Br J Cancer 2011; 104: 915-20.
17. Bais AG, van Kemenade FJ, Berkhof J, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007; 120: 1505-10.
18. Sanner K, Wikstrom I, Strand A, et al. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 2009; 101: 871-4.
19. Wikstrom I, Lindell M, Sanner K, et al. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer 2011; 105: 337-9.
20. Gok M, van Kemenade FJ, Heideman DA, et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer 2012; 130: 1128-35.
21. Szarewski A, Cadman L, Mallett S, et al. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007; 14: 34-42.
22. Snijders PJ, Verhoef VM, Arbyn M, et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013; 132: 2223-36.
23. Sammanställning av några kvalitetsdata 2010 gällande cervixcancerprevention i Västra Sverige [Compilation of quality data from 2010 concerning prevention of cervical cancer in West Sweden]. (in Swedish). Regionalt Cancercentrum Väst, 2011.
24. Socialstyrelsen. Gynekologisk cellprovskontroll. Förslag till ett screeningprogram 1998 [Guidelines for cervical screening] (in Swedish) SoS report 1998:15 Stockholm: National Board of Health and Welfare, 1998.
25. Barken SS, Rebolj M, Andersen ES, et al. Frequency of cervical intraepithelial neoplasia treatment in a well-screened population. Int J Cancer 2012; 130: 2438-44.
26. Schultz K, Altman D, Moher D,. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332.
27. Giorgi Rossi P, Marsili LM, Camilloni L, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer 2011; 104: 248-54.
28. Socialstyrelsen. Background to a vaccination programme for the human papilloma virus in Sweden 2007 Stockholm: National Board of Health and Welfare, 2008.
29. Andrae B, Andersson TM, Lambert PC, et al. Screening and cervical cancer cure: population based cohort study. BMJ 2012; 344: e900.